These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32502201)

  • 21. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial Cell-Pericyte Interactions in the Pathogenesis of Cerebral Cavernous Malformations (CCMs).
    Min W; Zhou JH
    Cold Spring Harb Perspect Med; 2023 Mar; 13(3):. PubMed ID: 35667709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of transmembrane endothelial junction proteins in human cerebral cavernous malformations.
    Burkhardt JK; Schmidt D; Schoenauer R; Brokopp C; Agarkova I; Bozinov O; Bertalanffy H; Hoerstrup SP
    Neurosurg Focus; 2010 Sep; 29(3):E3. PubMed ID: 20809761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-22 regulates inflammation and angiogenesis via targeting VE-cadherin.
    Gu W; Zhan H; Zhou XY; Yao L; Yan M; Chen A; Liu J; Ren X; Zhang X; Liu JX; Liu G
    FEBS Lett; 2017 Feb; 591(3):513-526. PubMed ID: 28112401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses.
    Finetti F; Schiavo I; Ercoli J; Zotta A; Boda E; Retta SF; Trabalzini L
    Cell Signal; 2020 Apr; 68():109527. PubMed ID: 31917192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
    Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E
    FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Chronic Mouse Model of Cerebral Cavernous Malformations.
    Cardoso C; Arnould M; De Luca C; Otten C; Abdelilah-Seyfried S; Heredia A; Leutenegger AL; Schwaninger M; Tournier-Lasserve E; Boulday G
    Stroke; 2020 Apr; 51(4):1272-1278. PubMed ID: 31992178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
    Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
    Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.
    Wang H; Pan Y; Zhang Z; Li X; Xu Z; Suo Y; Li W; Wang Y
    J Mol Neurosci; 2017 Feb; 61(2):221-226. PubMed ID: 28160210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.
    Phillips CM; Stamatovic SM; Keep RF; Andjelkovic AV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
    Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
    J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel CCM2 missense variants abrogating the CCM1-CCM2 interaction cause cerebral cavernous malformations.
    Bergametti F; Viot G; Verny C; Brechard MP; Denier C; Labauge P; Petit P; Nouet A; Viallet F; Chaussenot A; Hervé D; Tournier-Lasserve E; Riant F
    J Med Genet; 2020 Jun; 57(6):400-404. PubMed ID: 31937560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.
    Di Modica M; Regondi V; Sandri M; Iorio MV; Zanetti A; Tagliabue E; Casalini P; Triulzi T
    Cancer Lett; 2017 Jan; 384():94-100. PubMed ID: 27693459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.
    Yang C; Nicholas VH; Zhao J; Wu B; Zhong H; Li Y; Xu Y
    J Mol Neurosci; 2017 Apr; 61(4):511-523. PubMed ID: 28255959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel deletion mutation in CCM1 gene (krit1) is detected in a Chinese family with cerebral cavernous malformations.
    Ji BH; Qin W; Sun T; Feng GY; He L; Wang YJ
    Yi Chuan Xue Bao; 2006 Feb; 33(2):105-10. PubMed ID: 16529293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.
    Choi JP; Wang R; Yang X; Wang X; Wang L; Ting KK; Foley M; Cogger V; Yang Z; Liu F; Han Z; Liu R; Baell J; Zheng X
    Sci Adv; 2018 Nov; 4(11):eaau0731. PubMed ID: 30417093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCM1 regulates vascular-lumen organization by inducing endothelial polarity.
    Lampugnani MG; Orsenigo F; Rudini N; Maddaluno L; Boulday G; Chapon F; Dejana E
    J Cell Sci; 2010 Apr; 123(Pt 7):1073-80. PubMed ID: 20332120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.
    Castro M; Laviña B; Ando K; Álvarez-Aznar A; Abu Taha A; Brakebusch C; Dejana E; Betsholtz C; Gaengel K
    Circ Res; 2019 Apr; 124(8):1240-1252. PubMed ID: 30732528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis.
    Miyazaki T; Taketomi Y; Takimoto M; Lei XF; Arita S; Kim-Kaneyama JR; Arata S; Ohata H; Ota H; Murakami M; Miyazaki A
    Circulation; 2011 Dec; 124(23):2522-32. PubMed ID: 22064597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.